
Opinion|Videos|February 28, 2025
Strategies for Managing FOLFOX Toxicity in Upper GI Cancer
Experts discuss the most common adverse events associated with the FOLFOX regimen and effective strategies for early detection and management.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What are the most common adverse events associated with FOLFOX, and what strategies are effective for early detection and management?
Advertisement
Related to this article

In the phase 2 EVITA trial, vitamin C did not slow clonal growth but was linked to fewer serious adverse events and longer exploratory survival.

In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.

Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.

Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.

At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.

At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.

At ASTRO 2026, Dr. Mishaal Munir details how nurse-led triage workflows and prompt symptom escalations improve care for breast cancer brain metastases.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Automated Breast Ultrasound Tied to Fewer False-Positives in Dense Breasts
2
Beyond the Treatment Center: Exploring Equine Assisted Wellness
3
Future Directions in Metastatic Triple-Negative Breast Cancer Care
4
Delaying BSO to Age 50 Leaves BRCA1 Carriers With 24% Ovarian Cancer Risk
5

